An economic evaluation of topical treatments for actinic keratosis

References

• Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000; 42((1 Pt 2))4–7
   Google Scholar
• Marks R. An overview of skin cancers.Incidence and causation. Cancer. 1995; 75((2 suppl))607–12
   Google Scholar
• Ehrig T, Cockerell C, Piacquadio D, Dromgoole S. Actinic keratoses and the incidence of occult squamous cell carcinoma: A clinical–histopathologic correlation. Dermatol Surg. 2006; 32: 1261–5
   PubMedGoogle Scholar
• Memon AA, Tomenson JA, Bothwell J, Friedmann PS. Prevalence of solar damage and actinic keratosis in a Merseyside population. BrJ Dermatol. 2000; 142: 1154–9
   PubMed Web of Science ®Google Scholar
• Harvey I, Frankel S, Marks R, Shalom D, Nolan-farrell M. Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study. Br J Cancer. 1996; 74: 1302–7
   PubMed Web of Science ®Google Scholar
• De Berker D, McGregor JM, Hughes BR. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007; 156: 222–30
   PubMed Web of Science ®Google Scholar
• Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: Report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002; 146: 552–67
   PubMed Web of Science ®Google Scholar
• Briggs AH, Gray AM. Handling uncertainty in economic evaluations of healthcare interventions. BMJ. 1999; 319: 635–8
   PubMed Web of Science ®Google Scholar
• Mcintyre WJ, Downs MR, Bedwell SA. Treatment options for actinic keratoses. Am Fam Physician. 2007; 76: 667–71
   PubMed Web of Science ®Google Scholar
• Tarstedt M. A multicentre, phase III, randomised study of photodynamic therapy (PDT) with Metvix® 160 mg/g cream comparing two treatment regimens in patients with actinic keratosis. Oslo: Photocure ASA; 24 June 2003. Report No.: PC T311/01.
   Google Scholar
• Foley P. A multicentre, phase III, randomised study of photodynamic therapy (PDT) with Metvix® 160 mg/g cream in comparison with cryotherapy and PDT with placebo cream in patients with actinic keratosis. Oslo: Photocure ASA; 25 Jan 2001. Report No.: PC T305/99.
   Google Scholar
• Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol. 2005; 85: 424–8
   PubMed Web of Science ®Google Scholar
• Alomar A, Bichel J, Mcrae S. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol. 2007; 157: 133–41
   PubMed Web of Science ®Google Scholar
• Jorizzo J, Dinehart S, Matheson R, Moore JK, Ling M, Fox TL, et al. Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. J Am Acad Dermatol. 2007; 57: 265–8
   PubMed Web of Science ®Google Scholar
• Loven K, Stein L, Furst K, Levy S. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther. 2002; 24: 990–1000
   PubMed Web of Science ®Google Scholar
• Krawtchenko N, Roewert-huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: A comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007; 157((suppl 2))34–40
   PubMed Web of Science ®Google Scholar
• Tanghetti E, Werschler P. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp. J Drugs Dermatol. 2007; 6: 144–7
   PubMedGoogle Scholar
• British National Formulary. 11 September 2008 [cited 2008 Nov 28]; 56.URL:. http://www.bnf.org
   Google Scholar
• Perrett CM, Mcgregor JM, Warwick J, Karran P, Leigh IM, Proby CM, et al. Treatment of post-transplant premalignant skin disease: A randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol. 2007; 156: 320–8
   PubMed Web of Science ®Google Scholar
• Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: A prospective, randomized study. J Dermatolog Treat. 2003; 14: 99–106.
   PubMedGoogle Scholar
• Rives V, Sarkany M. Management of superficial basal cell carcinoma (sBCC) with METVIX® (MAL-PDT) in real life practice in the Belgian population. 16th Congress of the European Academy of Dermatology and Venereology; 2007 Vienna, Austria.
   Google Scholar
• Galderma Watford, Hertfordshire, UK Ltd. Summary of product characteristics: Metvix. Dec 2005.
   Google Scholar
• Meda Pharmaceuticals, Takeley, Bishop's Stortford, UK. Summary of product characteristics: Aldara 5% cream. 17 February 2009.
   Google Scholar
• Valeant Pharmaceuticals Ltd, Basingstoke, Hampshire, UK. Summary of product characteristics: Efudix. Apr 2005.
   Google Scholar
• NHS. Reference costs 2002/3. 5 February 2004. URL:. http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4070195&chk=UzhHA3.
   Google Scholar
• NHS. Reference costs 2006/7. January 2008. URL:. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_074072.
   Google Scholar
• Curtis LaNA. Unit costs of health and social care 2007. URL: http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007.pdf.
   Google Scholar
• UCSHC 2007. Inflation indices; 2007: 185-6. URL:. http://www.pssru.ac.uk/pdf/uc/uc2007/uc2007_inflationindices
   Google Scholar
• Haymarket Group. eMIMS. 17 January 2008. URL:. http://www.healthcarerepublic.com/
   Google Scholar
• Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I, et al. Intraindividual, right–left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: A multicentre, randomized controlled study. Br J Dermatol. 2006; 155: 1029–36
   PubMed Web of Science ®Google Scholar
• Higashi MK, Veenstra DL, Langley PC. Health economic evaluation of non-melanoma skin cancer and actinic keratosis. Pharmacoeconomics. 2004; 22: 83–94
   Google Scholar
• Caekelbergh K, Annemans L, Lambert J, Roelandts R. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma. Br J Dermatol. 2006; 155: 784–90
   PubMed Web of Science ®Google Scholar
• Lebwohl M. Actinic keratosis: Epidemiology and progression to squamous cell carcinoma. Br J Dermatol. 2003; 149( (suppl 66))31–3
   Google Scholar
• Drummond MF. The future of pharmacoeconomics: Bridging science and practice. Clin Ther. 1996; 18: 969–78
   PubMed Web of Science ®Google Scholar
• Ellis CN, Reiter KL, Wheeler JR, Fendrick AM. Economic analysis in dermatology. J Am Acad Dermatol. 2002; 46: 271–83
   Google Scholar
• Campbell DT., Stanley JC. Experimental and Quasi-Experimental Designs for Research. Rand McNally, Chicago 1963
   Google Scholar
• Annemans L, Caekelbergh K, Roelandts R, Boonen H, Leys C, Nikkels A, et al. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoms. Eur J Dermatol 2008
   Google Scholar
• Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R. Adherence in dermatology: A review of the last 20 years. J Dermatolog Treat. 2006; 17: 136–42
   PubMed Web of Science ®Google Scholar
• Spencer JM, Hazan C, Hsiung SH, Robins P. Therapeutic decision-making in the therapy of actinic keratoses. J Drugs Dermatol. 2005; 4: 296–301
   PubMedGoogle Scholar
• Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, et al. Generalisability in economic evaluation studies in healthcare: A review and case studies. Health Technol Assess. 2004; 8: iii–192
   Web of Science ®Google Scholar
• Claxton K, Sculpher M, Mccabe C, Briggs A, Akehurst R, Buxton M, et al. Probabilistic sensitivity analysis for NICE technology assessment: Not an optional extra. Health Econ. 2005; 14: 339–47
   PubMed Web of Science ®Google Scholar